hsCRP serves as an alternative predictor of CVD, endothelial dysfunction, and as a biomarker of systemic low-grade inflammation.[ 42 ] It was reduced by 0.13 mg/L (5.98%) at 54 weeks of TU therapy but did not reach statistical significance ( P = 0.072).
← all excerpts
Effect of Testosterone Undecanoate on Sexual Functions, Glycaemic Parameters, and Cardiovascular Risk Factors in Hpogonadal Men with Type 2 Diabetes Mellitus.
1
0.0720
0.0720